Pharmacogenomics in Early-Phase Clinical Development

Pharmacogenomics - United Kingdom
doi 10.2217/pgs.13.81
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

Pharmacogenomics in Early-Phase Oncology Clinical Trials: Is There a Sweet Spot in Phase II?

Clinical Cancer Research
Cancer ResearchOncology
2012English

Pharmacogenomics in Clinical Practice and Drug Development

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2012English

Pharmacogenomics in Clinical Practice and Drug Development

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2012English

Clinical Pharmacogenomics

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Clinical Impact of Pharmacogenomics

Drug Metabolism and Pharmacokinetics
1999English

Pharmacogenomics Research and Clinical Implementation in Brazil

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2019English

Clinical Pharmacogenomics of Thiopurine S-Methyltransferase

Current Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2006English

Pharmacogenomics Clinical Annotation Tool (Pharm CAT )

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

Early HTA in Pharmacogenomics: A Case Example in Cardiovascular Drugs

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy